Omalizumab improves angioedema-related quality of life impairment in chronic spontaneous urticaria patients: Results from the X-ACT study

被引：0
|
作者：
Weller, Karsten [1 ]
Staubach, Petra [2 ]
Metz, Martin [1 ]
Chapman-Rothe, Nadine [3 ]
Sieder, Christian [3 ]
Brautigam, Matthias [3 ]
Maurer, Marcus [1 ]
机构：
[1] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany
[2] Univ Med Ctr, Dept Dermatol, Utrecht, Netherlands
[3] Novartis Pharmaceut, Basel, Switzerland
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6835
引用
收藏
页码：AB209 / AB209
页数：1
相关论文
共 50 条
  • [41] Lanadelumab Markedly Improves Health-related Quality of Life in Hereditary Angioedema Patients in the HELP Study
    Lumry, W. R.
    Weller, K.
    Magerl, M.
    Lu, P.
    Jain, G.
    Lewis, H.
    Bruelle, J.
    Maurer, M.
    SWISS MEDICAL WEEKLY, 2018, 148 : 28S - 28S
  • [42] It is never too late to treat chronic spontaneous urticaria with omalizumab: Real-life data from a multicenter observational study focusing on elderly patients
    Martina, Emanuela
    Damiani, Giovanni
    Grieco, Teresa
    Foti, Caterina
    Pigatto, Paolo Daniele Maria
    Offidani, Annamaria
    DERMATOLOGIC THERAPY, 2021, 34 (02)
  • [43] Lanadelumab Markedly Improves Health-related Quality of Life in Hereditary Angioedema Patients in the HELP Study
    Lumry, William R.
    Weller, Karsten
    Magerl, Markus
    Schranz, Jennifer
    Jain, Gagan
    Doll, Helen
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB47 - AB47
  • [44] Omalizumab reduces Symptoms and improves health related quality of life in Patients with chronic spontaneous Urticaria: A post-hoc-Analysis of Data from three randomised, double blind, placebo-controlled Phase-III-Studies
    Maurer, M.
    Casale, T.
    Saini, S. S.
    Bernstein, J. A.
    Kaplan, A.
    Rosen, K.
    Li, J.
    Georgiou, P.
    Balp, M. M.
    Canvin, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 120 - 121
  • [45] REMIBRUTINIB IMPROVES CHRONIC SPONTANEOUS URTICARIA IN PATIENTS IRRESPECTIVE OF CU-INDEX: RESULTS FROM PHASE 2B STUDY
    Carr, W.
    Sitz, K.
    Jain, V.
    Gimenez-Arnau, A.
    Lheritier, K.
    Nikolaev, L.
    Haemmerle, S.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S11 - S11
  • [46] Garadacimab prophylaxis improves quality of life in adult and adolescent patients with hereditary angioedema: Results from a multicentre Phase 3 study
    Lumry, W.
    Magerl, M.
    Craig, T. J.
    Farkas, H.
    Yang, W.
    Stroes, E. S.
    Saguer, I. Martinez
    Aygoeren-Puersuen, E.
    Staubach, P.
    Treudler, R.
    Itzler, R.
    Feuersenger, H.
    Pragst, I.
    Reshef, A.
    ALLERGY, 2023, 78 : 114 - 115
  • [47] Omalizumab in the treatment of chronic spontaneous urticaria in pediatric patients from the age of 6 years (real-life experience of one center)
    Petrovicova, O.
    Banovcin, P.
    Malicherova, E. Jurkova
    Bobcakova, A.
    Jesenak, M.
    ALLERGY, 2023, 78
  • [48] Omalizumab normalizes gene expression in lesional skin of patients with chronic spontaneous urticaria: Results from a randomized, double-blind, placebo-controlled study
    Metz, Martin
    Torene, Rebecca
    Letzkus, Martin
    Hartmann, Nicole
    Staubach, Petra
    Bauer, Andrea
    Brehler, Randolf
    Ashton-Chess, Joanna
    Maurer, Marcus
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB64 - AB64
  • [49] Remibrutinib Treatment Improves Itch and Sleep in Chronic Spontaneous Urticaria Patients: Phase 2b Study Results
    Hsu, Connie
    Snyder, Robert
    Clore, Lee
    Jain, Vipul
    Gimenez-Arnau, Ana
    Lheritier, Karine
    Walsh, Pauline
    Haemmerle, Sibylle
    Wells, Michael
    Nikolaev, Ivan
    Maurer, Marcus
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB82 - AB82
  • [50] REMIBRUTINIB TREATMENT IMPROVES SLEEP AND ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA PATIENTS: PHASE 2B STUDY RESULTS
    Clore, L.
    Jain, V.
    Gimenez-Arnau, A.
    Lheritier, K.
    Walsh, P.
    Haemmerle, S.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S32 - S32
12345